Discover
ELDN
Eledon Pharmaceuticals, Inc.
2.62
2 x 1.92
2 x 3.53
bid
ask
-
0.03
1.13%
2 @ 07:44 PM
2.71 +0.09 (3.44%)
| Ytd | 73.51% | |
| 1y | 2.75% |
2.57
day range
2.67
1.39
52 week range
4.36
| Open | 2.65 | Prev Close | 2.65 | Low | 2.57 | High | 2.67 | Mkt Cap | 212.90M |
| Vol | 828.99K | Avg Vol | 1.23M | EPS | -0.90 | P/E | N/A | Forward P/E | -3.49 |
| Beta | 0.93 | Short Ratio | 0.75 | Inst. Own | 42.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 3.39 | 200-d Avg | 2.98 | 1yr Est | 12.50 |
| Income Statement | |||
| Operating Expenses | 22.87M | ||
| Research and Development Expense | 18.23M | ||
| Selling, General and Administrative Expense | 4.64M | ||
| Operating Income | -22.87M | ||
| Net Income | -31.63M | ||
| Net Income Common Stock | -31.63M | ||
| Net Income Common Stock (USD) | -31.63M | ||
| Consolidated Income | -31.63M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -31.63M | ||
| Earning Before Interest & Taxes (USD) | -31.63M | ||
| Weighted Average Shares | 113.63M | ||
| Weighted Average Shares Diluted | 113.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.80M | ||
| Cash and Equivalents (USD) | 6.80M | ||
| Investments | 81.95M | ||
| Investments Current | 81.95M | ||
| Current Assets | 93.09M | ||
| Property, Plant & Equipment Net | 445.00K | ||
| Total Assets | 126.09M | ||
| Debt Current | 381.00K | ||
| Total Debt | 467.00K | ||
| Current Liabilities | 11.79M | ||
| Debt Non-Current | 86.00K | ||
| Total Liabilities | 54.06M | ||
| Accumulated Retained Earnings (Deficit) | -471.86M | ||
| Accumulated Other Comprehensive Income | -114.00K | ||
| Shareholders Equity | 33.01M | ||
| Shareholders Equity (USD) | 33.01M | ||
| Assets Non-Current | 33.00M | ||
| Total Debt (USD) | 467.00K | ||
| Liabilities Non-Current | 42.27M | ||
| Trade and Non-Trade Payables | 3.21M | ||
| Tax Liabilities | 2.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 85.00K | ||
| Net Cash Flow from Financing | 91.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 651.00K | ||
| Issuance (Purchase) of Equity Shares | 91.00K | ||
| Net Cash Flow from Investing | 23.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 23.24M | ||
| Net Cash Flow from Operations | -22.68M | ||
| Share Based Compensation | 3.15M | ||